Companies

Companies

featured image of Breakthrough Partnership: GSK and Elegen Revolutionize DNA Medicines

Breakthrough Partnership: GSK and Elegen Revolutionize DNA Medicines

BIOT

🔬 GSK teams up with Elegen Bio to develop DNA-based medicines and vaccines, revolutionizing the field of biotechnology. 💉💊

featured image of Patient Advocate Slams FDA's CAR-T Warning Labels: Is Patient Safety at Risk?

Patient Advocate Slams FDA’s CAR-T Warning Labels: Is Patient Safety at Risk?

BIOT

🔺 Patient advocate slams FDA decision on CAR-T warning labels, arguing it undermines patient knowledge and autonomy. 🔺 Warning labels may deter patients from seeking life-saving CAR-T therapies. 🔺 Advocates prioritize informed consent and patient education over warnings. 🔺 Critics fear labels could cause unnecessary fear and anxiety. 🔺 FDA decision raises concerns on patient safety vs. access to innovative therapies.

featured image of World's First CRISPR Cell Therapy Approved for Sickle Cell - Solvias to Perform Testing

World’s First CRISPR Cell Therapy Approved for Sickle Cell – Solvias to Perform Testing

BIOT

📰 Solvias will perform release testing on CASGEVY, the world's first CRISPRCas9 genome-edited cell therapy. 🧪💊🔬✅🌍

featured image of Dutch Biotech Firm Raises €75m to Fight Diseases

Dutch Biotech Firm Raises €75m to Fight Diseases

BIOT

💰 Dutch biotech firm Forbion leads €75m funding for Calluna Pharma, a newly formed company targeting inflammatory and fibrotic diseases.

featured image of Catalent's Game-Changing CAR-T Platform Revolutionizes Immunocellular Therapy

Catalent’s Game-Changing CAR-T Platform Revolutionizes Immunocellular Therapy

BIOT

🚀 Catalent launches a plug-and-play CAR-T platform 🛠️ designed to streamline development and manufacturing of immunocellular therapies. 🌟🔬💼

featured image of Roche Abandons AC Immune Collaboration Returns Drugs

Roche Abandons AC Immune Collaboration Returns Drugs

BIOT

📰 Roche's US subsidiary, Genentech, 🚢 jumps ship on AC Immune after disappointing study results. 🧪🔍 Crenezumab and Semorinemab returned. 💪 AC Immune remains focused on other therapies. 💰📅

featured image of EU Decision on Genomic Techniques: Last Chance Before Elections

EU Decision on Genomic Techniques: Last Chance Before Elections

BIOT

📅 On January 22, 2024, EU Parliament calls for patent ban on NGT-1 breeds. Tomorrow, ENVI Committee gives input on draft law. Germany, Belgium, & Bulgaria abstain. Poland supports product labeling. Decision crucial before elections & new European Commission.

featured image of Gilead Ditches Oceanside Boosts Biologics in Foster City!

Gilead Ditches Oceanside Boosts Biologics in Foster City!

BIOT

🚫 Gilead cancels Oceanside expansion plans 🌊, shifts biologics production to Foster City 🏙️. Read more about the move! 💥

featured image of Unleashing Women's Potential in Advanced Therapies

Unleashing Women’s Potential in Advanced Therapies

BIOT

📢 Women in advanced therapies: 'Get comfortable being uncomfortable' and drive change. 💪 Seek out challenging opportunities, take risks, and make a difference! 🌍🚀🌟🙋‍♀️

featured image of Alvotech's Biosimilar Plant Receives Second FDA Violation

Alvotech’s Biosimilar Plant Receives Second FDA Violation

BIOT

🔬🚨 Alvotech, a biopharmaceutical company, receives another FDA observation at its biosimilar plant, potentially delaying product approval.